15.85
price up icon5.46%   0.82
after-market アフターアワーズ: 15.85
loading
前日終値:
$15.03
開ける:
$15.34
24時間の取引高:
798.23K
Relative Volume:
1.29
時価総額:
$482.29M
収益:
$17.16M
当期純損益:
$-163.62M
株価収益率:
-2.6069
EPS:
-6.08
ネットキャッシュフロー:
$-121.61M
1週間 パフォーマンス:
+11.54%
1か月 パフォーマンス:
-0.88%
6か月 パフォーマンス:
-54.00%
1年 パフォーマンス:
-31.86%
1日の値動き範囲:
Value
$15.06
$16.23
1週間の範囲:
Value
$13.51
$16.23
52週間の値動き範囲:
Value
$12.51
$41.31

Anaptysbio Inc Stock (ANAB) Company Profile

Name
名前
Anaptysbio Inc
Name
セクター
Healthcare (1174)
Name
電話
858-362-6295
Name
住所
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Name
職員
117
Name
Twitter
@anaptysbio
Name
次回の収益日
2024-11-08
Name
最新のSEC提出書
Name
ANAB's Discussions on Twitter

ANAB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ANAB
Anaptysbio Inc
15.85 482.29M 17.16M -163.62M -121.61M -6.08
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.00 108.68B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
681.58 74.90B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
640.52 38.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
246.27 31.76B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
111.93 26.83B 3.30B -501.07M 1.03B -2.1146

Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-11 ダウングレード H.C. Wainwright Buy → Neutral
2024-12-02 ダウングレード BTIG Research Buy → Neutral
2024-07-22 開始されました H.C. Wainwright Buy
2024-07-19 アップグレード JP Morgan Neutral → Overweight
2024-04-16 開始されました Leerink Partners Outperform
2024-04-11 開始されました Wells Fargo Overweight
2024-03-12 アップグレード Wedbush Neutral → Outperform
2024-02-26 開始されました BTIG Research Buy
2024-02-21 開始されました Stifel Buy
2024-02-16 開始されました Piper Sandler Overweight
2023-05-22 アップグレード JP Morgan Underweight → Neutral
2023-05-18 開始されました TD Cowen Outperform
2023-01-06 ダウングレード Raymond James Outperform → Mkt Perform
2022-11-01 アップグレード Guggenheim Neutral → Buy
2022-09-19 再開されました H.C. Wainwright Buy
2022-09-13 ダウングレード Truist Buy → Hold
2022-09-01 開始されました Raymond James Outperform
2022-03-22 ダウングレード Guggenheim Buy → Neutral
2021-06-22 開始されました H.C. Wainwright Buy
2021-05-21 開始されました UBS Neutral
2021-03-16 アップグレード Truist Hold → Buy
2021-03-09 ダウングレード Wedbush Outperform → Neutral
2021-03-08 ダウングレード JP Morgan Overweight → Underweight
2021-02-11 アップグレード JP Morgan Underweight → Overweight
2020-10-27 アップグレード Wedbush Neutral → Outperform
2020-10-14 アップグレード Guggenheim Neutral → Buy
2019-11-08 ダウングレード JP Morgan Overweight → Underweight
2019-11-08 ダウングレード Jefferies Buy → Hold
2019-11-08 ダウングレード SunTrust Buy → Hold
2019-11-08 ダウングレード Wedbush Outperform → Neutral
2019-06-21 ダウングレード Credit Suisse Outperform → Neutral
2019-06-21 ダウングレード Stifel Buy → Hold
2018-12-20 開始されました H.C. Wainwright Buy
2018-11-21 開始されました JP Morgan Overweight
2018-07-19 開始されました Credit Suisse Outperform
2018-04-04 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2018-03-27 繰り返されました Stifel Buy
2018-03-06 繰り返されました Stifel Buy
2018-02-15 繰り返されました SunTrust Buy
2018-01-23 繰り返されました Credit Suisse Outperform
2017-11-15 開始されました SunTrust Buy
2017-11-09 開始されました Jefferies Buy
2017-10-11 繰り返されました RBC Capital Mkts Outperform
2017-09-15 開始されました RBC Capital Mkts Outperform
すべてを表示

Anaptysbio Inc (ANAB) 最新ニュース

pulisher
Jan 18, 2025

Shareholders May Not Overlook AnaptysBio Insiders Selling US$3.6m In Stock - Simply Wall St

Jan 18, 2025
pulisher
Jan 17, 2025

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Jan 17, 2025
pulisher
Jan 13, 2025

How AnaptysBio (ANAB) Stock Stands Out in a Strong Industry - Yahoo Finance

Jan 13, 2025
pulisher
Jan 13, 2025

Barclays PLC Grows Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Jan 13, 2025
pulisher
Jan 12, 2025

Anaptysbio announces clearance of U.S., India, U.K. CTA for ANB020 - Reuters

Jan 12, 2025
pulisher
Jan 12, 2025

Big Biotech Fund Loaded Up on Two Stocks - Barron's

Jan 12, 2025
pulisher
Jan 09, 2025

Are Medical Stocks Lagging United Therapeutics (UTHR) This Year? - Yahoo Finance

Jan 09, 2025
pulisher
Jan 07, 2025

Anaptys to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times

Jan 07, 2025
pulisher
Jan 07, 2025

AnaptysBio CEO to Present at J.P. Morgan Healthcare Conference 2025 - StockTitan

Jan 07, 2025
pulisher
Jan 06, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Jan 06, 2025
pulisher
Jan 06, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Jan 06, 2025
pulisher
Jan 03, 2025

EcoR1 Capital, LLC Increases Stake in AnaptysBio Inc - GuruFocus.com

Jan 03, 2025
pulisher
Jan 02, 2025

Objective long/short (ANAB) Report - Stock Traders Daily

Jan 02, 2025
pulisher
Jan 02, 2025

Ecor1 Capital, Llc Acquires 6,646 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) Stock - MarketBeat

Jan 02, 2025
pulisher
Jan 02, 2025

Ecor1 Capital's Oleg Nodelman acquires $1.1m in AnaptysBio stock By Investing.com - Investing.com South Africa

Jan 02, 2025
pulisher
Jan 02, 2025

Ecor1 Capital's Oleg Nodelman acquires $1.1m in AnaptysBio stock - Investing.com

Jan 02, 2025
pulisher
Dec 30, 2024

Geode Capital Management LLC Increases Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Dec 30, 2024
pulisher
Dec 29, 2024

AnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by Barclays PLC - Defense World

Dec 29, 2024
pulisher
Dec 23, 2024

AnaptysBio stock hits 52-week low at $14.11 amid market challenges - Investing.com

Dec 23, 2024
pulisher
Dec 23, 2024

How To Trade (ANAB) - Stock Traders Daily

Dec 23, 2024
pulisher
Dec 22, 2024

State Street Corp Sells 60,670 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Dec 22, 2024
pulisher
Dec 22, 2024

AnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by State Street Corp - MarketBeat

Dec 22, 2024
pulisher
Dec 21, 2024

JPMorgan Chase & Co. Lowers AnaptysBio (NASDAQ:ANAB) Price Target to $36.00 - Defense World

Dec 21, 2024
pulisher
Dec 21, 2024

Franklin Resources Inc. Has $12.31 Million Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

Dec 21, 2024
pulisher
Dec 20, 2024

Truist Financial Has Lowered Expectations for AnaptysBio (NASDAQ:ANAB) Stock Price - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

AnaptysBio (NASDAQ:ANAB) Given New $36.00 Price Target at JPMorgan Chase & Co. - MarketBeat

Dec 19, 2024
pulisher
Dec 19, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Raises Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Dec 19, 2024
pulisher
Dec 19, 2024

Wellington Management Group LLP Grows Stake in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Dec 19, 2024
pulisher
Dec 19, 2024

AnaptysBio shares target cut, hold rating kept on trial failure By Investing.com - Investing.com Canada

Dec 19, 2024
pulisher
Dec 18, 2024

AnaptysBio (NASDAQ:ANAB) Shares Gap UpStill a Buy? - MarketBeat

Dec 18, 2024
pulisher
Dec 18, 2024

Deep Dive Into AnaptysBio Stock: Analyst Perspectives (9 Ratings) - Benzinga

Dec 18, 2024
pulisher
Dec 18, 2024

AnaptysBio: Doubts About Cash And Upcoming Rheumatoid Arthritis Readout - Seeking Alpha

Dec 18, 2024
pulisher
Dec 18, 2024

AnaptysBio (NASDAQ:ANAB) Price Target Lowered to $20.00 at Truist Financial - MarketBeat

Dec 18, 2024
pulisher
Dec 16, 2024

AnaptysBio (NASDAQ:ANAB) Shares Up 9.1%Here's What Happened - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

AnaptysBio, Inc. (NASDAQ:ANAB) Sees Significant Growth in Short Interest - Defense World

Dec 16, 2024
pulisher
Dec 16, 2024

What is Wedbush’s Estimate for AnaptysBio FY2024 Earnings? - Defense World

Dec 16, 2024
pulisher
Dec 16, 2024

Short Interest in AnaptysBio, Inc. (NASDAQ:ANAB) Grows By 5.8% - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Wedbush Has Negative Forecast for AnaptysBio FY2024 Earnings - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Analysts Set Expectations for AnaptysBio FY2024 Earnings - MarketBeat

Dec 16, 2024
pulisher
Dec 15, 2024

Guggenheim Cuts AnaptysBio (NASDAQ:ANAB) Price Target to $36.00 - Defense World

Dec 15, 2024
pulisher
Dec 14, 2024

Q1 Earnings Forecast for AnaptysBio Issued By HC Wainwright - Defense World

Dec 14, 2024
pulisher
Dec 13, 2024

Charles Schwab Investment Management Inc. Has $5.37 Million Stake in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Dec 13, 2024
pulisher
Dec 13, 2024

AnaptysBio stock hits 52-week low at $14.2 amid market shifts - Investing.com Australia

Dec 13, 2024
pulisher
Dec 12, 2024

AnaptysBio (NASDAQ:ANAB investor three-year losses grow to 55% as the stock sheds US$261m this past week - Simply Wall St

Dec 12, 2024
pulisher
Dec 12, 2024

AnaptysBio Stock Under Pressure After Scrapping Eczema Drug Program: Retail Is Devastated - MSN

Dec 12, 2024
pulisher
Dec 12, 2024

AnaptysBio Stock Down as Eczema Study Fails to Meet Goals - MSN

Dec 12, 2024
pulisher
Dec 12, 2024

AnaptysBio shares target cut, maintains Buy rating on phase study results - Investing.com UK

Dec 12, 2024
pulisher
Dec 12, 2024

HC Wainwright & Co. Downgrades AnaptysBio (ANAB) - MSN

Dec 12, 2024
pulisher
Dec 12, 2024

AnaptysBio’s atopic dermatitis trial of BTLA agonist misses endpoints - Yahoo Finance

Dec 12, 2024
pulisher
Dec 12, 2024

AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Dec 12, 2024
pulisher
Dec 12, 2024

AnaptysBio stock hits 52-week low at $14.2 amid market shifts By Investing.com - Investing.com South Africa

Dec 12, 2024

Anaptysbio Inc (ANAB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Anaptysbio Inc (ANAB) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
EcoR1 Capital, LLC
Director
Dec 30 '24
Buy
12.92
65,184
842,060
7,860,180
EcoR1 Capital, LLC
Director
Dec 31 '24
Buy
12.93
13,268
171,513
7,873,448
EcoR1 Capital, LLC
Director
Jan 02 '25
Buy
12.95
6,646
86,070
7,880,094
RENTON HOLLINGS
Director
Nov 29 '24
Option Exercise
6.93
10,000
69,300
11,950
RENTON HOLLINGS
Director
Nov 29 '24
Sale
25.00
10,000
250,000
1,950
$30.75
price down icon 0.65%
$71.93
price down icon 0.75%
$19.03
price up icon 4.62%
$358.93
price down icon 2.04%
biotechnology ONC
$210.08
price up icon 2.31%
$111.93
price down icon 0.74%
大文字化:     |  ボリューム (24 時間):